Detalles de la búsqueda
1.
Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
Australas J Dermatol
; 65(3): 243-253, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572842
2.
Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
J Cutan Med Surg
; 28(1): 51-58, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189282
3.
Association of Nonmelanoma Skin Cancers, Melanoma, and Merkel Cell Carcinoma with Dermatologic Medications: A Case-Control Pharmacovigilance Study of the FDA Adverse Events Reporting System.
Dermatology
; 239(5): 694-699, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37054693
4.
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system.
J Eur Acad Dermatol Venereol
; 2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071595
5.
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
J Cutan Med Surg
; 27(1): 39-43, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495205
6.
Use of fractionated laser therapy for the treatment of androgenetic alopecia: a systematic review and meta-analysis.
Lasers Med Sci
; 39(1): 4, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087122
7.
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system.
Australas J Dermatol
; 63(2): 222-227, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316535
8.
Polydactylous Squamous Cell Carcinoma of the Nail Unit: A Structured Review of the Literature.
J Cutan Med Surg
; 25(3): 303-314, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256431
9.
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
Blood
; 128(9): 1226-33, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27458004
10.
Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study.
J Am Acad Dermatol
; 89(2): 408-410, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062463
11.
Annular plaques and nodules at vaccination sites in an infant.
Pediatr Dermatol
; 40(6): 1127-1129, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37970693
12.
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.
Blood
; 125(3): 483-91, 2015 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25395420
13.
Case/noncase analysis of the FDA Adverse Events Reporting System suggests higher reporting odds of photosensitivity and esophageal symptoms for sarecycline than of those for other tetracyclines.
J Am Acad Dermatol
; 87(5): 1150-1153, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192901
14.
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma.
Blood
; 124(4): 536-45, 2014 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24914135
15.
Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine.
Dermatol Online J
; 27(1)2021 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560802
16.
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Br J Haematol
; 168(4): 507-10, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25302557
17.
Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review.
J Dermatol
; 49(1): 190-196, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741345
18.
DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020.
Am J Clin Dermatol
; 22(6): 891-900, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287770
19.
Proteasome inhibitors block Ikaros degradation by lenalidomide in multiple myeloma.
Haematologica
; 100(8): e315-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25975838
20.
Punctate porokeratosis-pruritic and hyperkeratotic papules on the palms and feet.
Proc (Bayl Univ Med Cent)
; 33(3): 415-416, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675969